(Q43203420)

16 November 2017

title

Levetiracetam as add-on therapy in different subgroups of "benign" idiopathic focal epilepsies in childhood (English)

1 reference

16 November 2017

1 reference

C von Stülpnagel

1

1 reference

16 November 2017

G Kluger

series ordinal

2

1 reference

16 November 2017

S Leiz

series ordinal

3

1 reference

16 November 2017

H Holthausen

series ordinal

4

1 reference

16 November 2017

publication date

31 December 2009

1 reference

16 November 2017

1 reference

16 November 2017

volume

17

1 reference

16 November 2017

issue

2

1 reference

16 November 2017

page(s)

193-198

1 reference

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

16 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam: the preclinical profile of a new class of antiepileptic drugs?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam in pediatrics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam efficacy in epileptic syndromes with continuous spikes and waves during slow sleep: experience in 12 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam for benign epilepsy of childhood with centrotemporal spikes-three cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Successful treatment of pharmacoresistent continuous spike wave activity during slow sleep with levetiracetam

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam in children with refractory epilepsy: a multicenter open label study in Germany

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Treatment of partial seizures in childhood : an overview.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Management of Landau-Kleffner syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam Monotherapy in Children With Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Clinical experience with levetiracetam in childhood epilepsy: an add-on and mono-therapy trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Efficacy and safety of levetiracetam: an add-on trial in children with refractory epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Cognitive and behavioral effects of nocturnal epileptiform discharges in children with benign childhood epilepsy with centrotemporal spikes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Cognitive and behavioral problems in children with centrotemporal spikes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Coexistence of idiopathic rolandic epilepsy and CSWS in two families.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Atypical benign partial epilepsy of childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Benign childhood focal epilepsies: assessment of established and newly recognized syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Treatment of pediatric epilepsy: expert opinion, 2005.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Sulthiame as Monotherapy in Children with Benign Childhood Epilepsy with Centrotemporal Spikes: A 6-Month Randomized, Double-Blind, Placebo-Controlled Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

The influence of sulthiame on EEG in children with benign childhood epilepsy with centrotemporal spikes (BECTS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Treatment with Sulthiame (Ospolot) in benign partial epilepsy of childhood and related syndromes: an open clinical and EEG study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Spike-and-wave complexes and seizure exacerbation caused by carbamazepine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Epileptic negative myoclonus induced by carbamazepine in a child with BECTS. Benign childhood epilepsy with centrotemporal spikes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Oxcarbazepine and atypical evolution of benign idiopathic focal epilepsy of childhood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

The management of refractory idiopathic epilepsies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Antiepileptic drug treatment of benign childhood epilepsy with rolandic spikes: is it necessary?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Predictive factors of seizure frequency and duration of antiepileptic treatment in rolandic epilepsy: a retrospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Indication for anti-epileptic drug treatment of benign childhood epilepsy with centro-temporal spikes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Language dysfunction in children with Rolandic epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Written language skills in children with benign childhood epilepsy with centrotemporal spikes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

The neuropsychological and language profile of children with benign rolandic epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Evidence for a neurophysiologic auditory deficit in children with benign epilepsy with centro-temporal spikes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Cognition and behavior in children with benign epilepsy with centrotemporal spikes (BECTS).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Academic performance in children with rolandic epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Cortical auditory dysfunction in benign rolandic epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Electrophysiologic and neuropsychologic evaluation of patients with centrotemporal spikes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Attention impairment in rolandic epilepsy: systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Landau-Kleffner Syndrome: A Pharmacologic Study of Five Cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Treatment of epilepsy with electrical status epilepticus during slow sleep and its related disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Epilepsy with continuous spike-waves during slow sleep and its treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Treatment of "benign" partial epilepsies of childhood, including atypical forms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

A pilot study transitioning children onto levetiracetam monotherapy to improve language dysfunction associated with benign rolandic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam monotherapy for children and adolescents with benign rolandic seizures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Symptomatology in children with focal sharp waves of genetic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2009.10.024

10.1016/J.YEBEH.2009.10.024

7 January 2021

Identifiers

DOI

1 reference

16 November 2017

1 reference